Helicobacter pylori bacterial enzymes and surface components

Helicobacter pylori bacterial enzymes and surface components represent a diverse group of molecular targets essential for the bacterium's survival and pathogenicity within the human stomach (StatPearls, 2023). A primary enzyme target is urease, which catalyzes the hydrolysis of urea into ammonia and carbon dioxide, neutralizing local gastric acid to allow bacterial colonization (PubMed, 2022). Surface components include adhesins such as BabA and SabA, which mediate attachment to gastric epithelial cells, and the Type IV secretion system used to inject virulence factors like CagA into host cells (Nature Reviews Microbiology, 2023). Another critical surface-associated factor is the vacuolating cytotoxin (VacA), which induces pore formation in host cell membranes and modulates the host immune response (Journal of Biological Chemistry, 2021). Therapeutic intervention typically involves multi-drug regimens that combine antibiotics—targeting bacterial ribosomes or cell wall synthesis—with bismuth and acid-suppressing agents (American College of Gastroenterology, 2017). Eradication of these targets is the standard of care for treating peptic ulcer disease and preventing gastric adenocarcinoma or MALT lymphoma (World Health Organization, 2020). The increasing prevalence of antibiotic-resistant strains targeting these components remains a significant challenge in global clinical management (Lancet Infectious Diseases, 2022).

Other names

Helicobacter pylori virulence factorsH. pylori proteinsH. pylori antigensGastric helicobacter targets

The mechanisms of action for drugs targeting these components include the inhibition of bacterial cell wall synthesis via binding to penicillin-binding proteins (e.g., Amoxicillin), inhibition of protein synthesis by binding to the 30S or 50S ribosomal subunits (e.g., Tetracycline, Clarithromycin), and the inhibition of DNA replication and transcription (e.g., Levofloxacin, Metronidazole) (StatPearls, 2023). Additionally, bismuth salts exert direct antimicrobial effects and inhibit bacterial enzymes like urease, while specific urease inhibitors like acetohydroxamic acid prevent the neutralization of gastric acid (PubMed, 2022).